Neoadjuvant dabrafenib and trametinib for functional organ preservation in recurrent BRAF V600E-mutated papillary thyroid cancer
Janice L. Farlow, Hilary C. McCrary, Jennifer A. Sipos, John E. Phay, Bhavana Konda, Amit Agrawal
Topics & Concepts
DabrafenibTrametinibMedicinePapillary thyroid cancerThyroid cancerThyroidOncologyPathologyCancerCancer researchInternal medicineVemurafenibBiologyMAPK/ERK pathwayGeneticsMetastatic melanomaKinaseThyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid SurgeryHead and Neck Cancer Studies